Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02.
Murray KJ, Nelson DF, Scott C, Fischbach AJ, Porter A, Farnan N, Curran WJ Jr. Murray KJ, et al. Among authors: nelson df. Int J Radiat Oncol Biol Phys. 1995 Feb 1;31(3):453-9. doi: 10.1016/0360-3016(95)93160-9. Int J Radiat Oncol Biol Phys. 1995. PMID: 7852106 Free article. Clinical Trial.
Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02.
Donahue B, Scott CB, Nelson JS, Rotman M, Murray KJ, Nelson DF, Banker FL, Earle JD, Fischbach JA, Asbell SO, Gaspar LE, Markoe AM, Curran W. Donahue B, et al. Among authors: nelson js, nelson df. Int J Radiat Oncol Biol Phys. 1997 Jul 15;38(5):911-4. doi: 10.1016/s0360-3016(97)00126-0. Int J Radiat Oncol Biol Phys. 1997. PMID: 9276354 Free article. Clinical Trial.
Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710.
Colman H, Berkey BA, Maor MH, Groves MD, Schultz CJ, Vermeulen S, Nelson DF, Mehta MP, Yung WK; Radiation Therapy Oncology Group. Colman H, et al. Among authors: nelson df. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):818-24. doi: 10.1016/j.ijrobp.2006.05.021. Epub 2006 Aug 2. Int J Radiat Oncol Biol Phys. 2006. PMID: 16887285 Clinical Trial.
White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02).
Corn BW, Yousem DM, Scott CB, Rotman M, Asbell SO, Nelson DF, Martin L, Curran WJ Jr. Corn BW, et al. Among authors: nelson df. Cancer. 1994 Nov 15;74(10):2828-35. doi: 10.1002/1097-0142(19941115)74:10<2828::aid-cncr2820741014>3.0.co;2-k. Cancer. 1994. PMID: 7954244 Clinical Trial.
Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.
Nelson DF, Curran WJ Jr, Scott C, Nelson JS, Weinstein AS, Ahmad K, Constine LS, Murray K, Powlis WD, Mohiuddin M, et al. Nelson DF, et al. Among authors: nelson js. Int J Radiat Oncol Biol Phys. 1993 Jan 15;25(2):193-207. doi: 10.1016/0360-3016(93)90340-2. Int J Radiat Oncol Biol Phys. 1993. PMID: 8380567 Clinical Trial.
Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.
Werner-Wasik M, Scott CB, Nelson DF, Gaspar LE, Murray KJ, Fischbach JA, Nelson JS, Weinstein AS, Curran WJ Jr. Werner-Wasik M, et al. Among authors: nelson js, nelson df. Cancer. 1996 Apr 15;77(8):1535-43. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1535::AID-CNCR17>3.0.CO;2-0. Cancer. 1996. PMID: 8608540 Clinical Trial.
69 results